Mirae Asset Venture, GNTech Venture Capital invest US$19M in bioscience startup Hummingbird, to support antibody therapeutics development

Mirae Asset Venture Investment, South Korean VC firm that focusses on investing in enterprises and provides technology and management consulting, has co-invested US$19 million in Series B funding of bioscience startup Hummingbird Bioscience alongside GNTech Venture Capital, the corporate investment arm of Kooksoondang Brewery Co. Ltd.. Existing investors, Heritas Capital and Seeds Capital, as well […] The post Mirae Asset Venture, GNTech Venture Capital invest US$19M in bioscience startup Hummingbird, to support antibody therapeutics development appeared first on e27.